Optimizing combination targeted immunotoxin therapy: Insights from HER2 and EpCAM expression profiles.
A S Obozina1, A A Pakhomov2, A Yu Frolova2
1Moscow Center for Advanced Studies, Kulakova Str. 20, 123592, Moscow, Russia.
Biochemical and Biophysical Research Communications
|January 3, 2025
Summary
Combining targeted cancer therapies HER2 and EpCAM immunotoxins shows synergistic effects in specific cancer cells. Optimal efficacy requires high HER2 and moderate EpCAM expression for improved treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Immunotherapy
Background:
- Targeted monotherapy for cancer faces challenges due to multidrug resistance.
- Combination therapy using multiple targeted agents can overcome resistance by engaging different signaling pathways.
Purpose of the Study:
- To investigate the combined efficacy of anti-HER2 and anti-EpCAM immunotoxins on cancer cells.
- To determine optimal conditions for synergistic effects in HER2/EpCAM targeted therapy.
Main Methods:
- Utilized anti-HER2 (DARP_9.29-LoPE) and anti-EpCAM (DARP_EC1-LoPE) immunotoxins.
- Assessed effects on cancer cells with varying HER2 and EpCAM expression levels.
- Employed Chou-Talalay combination indices to evaluate synergy.
Main Results:
- Combined HER2/EpCAM therapy was less effective in cells with low HER2 and high EpCAM expression.
- Synergistic therapeutic effects were observed in cells with high HER2 and moderate EpCAM expression.
- An equimolar ratio of immunotoxins proved most effective for synergistic outcomes.
Conclusions:
- Identified specific expression levels (high HER2, moderate EpCAM) for optimal combination therapy.
- Findings guide the development of more effective dual-targeted cancer treatments.
- Optimizing combination HER2/EpCAM therapy can enhance treatment efficacy and overcome resistance.
Related Concept Videos
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K